Breaking News

BREAKING: More than Half of the U.S. House Asks Azar to Address Drug Makers’ 340B Actions Immediately

More than Half of the U.S. House Asks Azar to Address Drug Makers’ 340B Actions Immediately

More than half of the U.S. House today told U.S. Health and Human Services (HHS) Secretary Alex Azar “it is imperative that immediate action

Read More »

Breaking News

BREAKING: House Democratic Committee Chairs Say Drug Companies’ Actions Could Put 340B on “Treacherous Path”

House Democratic Committee Chairs Say Drug Companies’ Actions Could Put 340B on “Treacherous Path”

Letting drug manufacturers “pick and choose” which 340B program requirements they will comply with “could set us on a treacherous path where program participants might disregard

Read More »

Breaking News

BREAKING: HRSA is Investigating Whether Manufacturer Policies to Restrict 340B Pricing at Contract Pharmacies Violates Statute

HRSA is Investigating Whether Manufacturer Policies to Restrict 340B Pricing at Contract Pharmacies Violates Statute

In a major development, the Health Resources and Services Administration (HRSA) has told 340B Report that it is investigating whether recent manufacturer policies to restrict

Read More »

Breaking News

BREAKING: Eli Lilly Comment on Today's Actions

After publication, 340B Report received the following comment from Eli Lilly and Co. on its actions that we reported on today:

Report after report shows 340B is not working for patients and needs reform. We support recent executive action on

Read More »

Breaking News

BREAKING: Kalderos Wants to Give Drug Manufacturers a Way to Pay 340B Rebates in Lieu of Discounts

Kalderos Wants to Give Drug Manufacturers a Way to Pay 340B Rebates in Lieu of Discounts

Prescription drug information technology company Kalderos announced today it is launching a platform called 340B Pay on Sept. 8 “to facilitate 340B discounts

Read More »

Breaking News

BREAKING: Novartis the Latest to Seek 340B Contract Pharmacy Claims Data

A Message from Publisher and CEO Ted Slafsky: I hope all is well. For now, we have more requests for 340B Report sponsorships than space available. Fortunately, we are creating a new website and newsletter platform that will accommodate our growing

Read More »

Breaking News

BREAKING: AstraZeneca Raises the Ante in Drug Industry Push Against 340B Contract Pharmacy

AstraZeneca Raises the Ante in Drug Industry Push Against 340B Contract Pharmacy

Drug manufacturer AstraZeneca today sent letters to 340B covered entities and its wholesale pharmacy contacts telling them that, effective Oct. 1, it

Read More »

Breaking News

BREAKING: Omnicell Buys PSG’s 340B Line of Business, the Latest in a Trend of 340B TPA Acquisitions

Omnicell Buys PSG’s 340B Line of Business, the Latest in a Trend of 340B TPA Acquisitions

Omnicell Inc., a leading provider of automated drug dispensing systems and other prescription drug supply chain products and services, has agreed to buy Pharmaceutical

Read More »

Breaking News

BREAKING: Health Centers Challenge Administration Suggestions They Put 340B Profits Over Patients

Become a Sponsor

Health Centers Challenge Administration Suggestions They Put 340B Profits Over Patients

The nation’s community health centers last night struck back against a presidential executive order and Trump administration comments that

Read More »

Breaking News

BREAKING: Presidential Executive Order Targets 340B Health Centers’ Savings on Insulin and EpiPen

Become a Sponsor

Presidential Executive Order Targets 340B Health Center’ Savings on Insulin and EpiPen

Update, 9:50 p.m. EDT, July 24—National Association of Community Health Centers President and CEO Tom Van Coverden issued

Read More »
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live